SCHEMBL2092709

SCHEMBL2092709

Cc1ccc(CNC2CC[N]C2)s1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRMT6 Q96LA8 1/20 0.46
TP53 P04637 2/20 0.40
THRB P10828 1/20 0.40
ALDH1A1 P00352 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
ALOX15 P16050 1/20 0.36
ALOX12 P18054 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
MAOA P21397 1/20 0.35
MEN1 O00255 1/20 0.34
EPHX2 P34913 1/20 0.34
KMT2A Q03164 1/20 0.34
KDM4C Q9H3R0 1/20 0.34
ADRA1D P25100 1/20 0.32
CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21311973 0.82 PRMT6 (0.57) PRMT6TP53THRBALDH1A1NPC1
SCHEMBL3360573 0.78 PRMT6 (0.52) PRMT6TP53THRBALDH1A1NPC1
SCHEMBL2094368 0.74 KDM1A (0.46) ALDH1A1RAB9AMEN1KMT2A
SCHEMBL5778389 0.73 PRMT6 (0.46) PRMT6TP53THRBALDH1A1NPC1
SCHEMBL2092871 0.72 ALDH1A1 (0.41) ALDH1A1LMNAMAOAMEN1KMT2A
SCHEMBL2092320 0.69 GRIN2B (0.54) PRMT6RAB9AMEN1KMT2A
SCHEMBL2094309 0.68 MCHR1 (0.44)
SCHEMBL2096691 0.67 GRIN2B (0.42) RAB9AMEN1KMT2A
SCHEMBL2091680 0.67 ACHE (0.48) NPC1RAB9AMEN1KMT2A
SCHEMBL2092195 0.67 HRH3 (0.42) ALDH1A1RAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631570-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS Abbott Laboratories (US) 2006-03-08 EP claimed
WO-2004083207-A1 NAPHTHYRIDINE DERIVATIVES AS ANTIBACTERIAL AGENTS ABBOTT LABORATORIES (US) 2004-09-30 WO claimed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US claimed
US-8163769-B2 1,8-naphthyridine derivatives ABBOTT LABORATORIES (US) 2012-04-24 US disclosed
US-20030232818-A1 Antibacterial compounds ABBVIE INC. 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232818-A1 Antibacterial compounds PGLS, UGT1A1, CASP1 PRMT6 4276/4885TP53 3511/4885THRB 3698/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.